SCHEMBL20108905

SCHEMBL20108905

O=P(c1ccccc1)(c1ccccc1)c1c2ccccc2c(-c2ccc3ccc4ccc(-c5ccncc5)nc4c3n2)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 6/20 0.39
CYP3A4 P08684 5/20 0.39
AR P10275 2/20 0.39
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
TOP1 P11387 1/20 0.35
DHODH Q02127 1/20 0.34
PARP1 P09874 1/20 0.34
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
NPSR1 Q6W5P4 1/20 0.33
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20108857 0.92 PARP1 (0.40) CYP2C9RAB9ATOP1PARP1KDM4E
SCHEMBL20108833 0.84 CCR1 (0.41) CYP3A4ARCYP2D6TOP1KDM4E
SCHEMBL20108897 0.83 CYP2C9 (0.46) CYP2C9CYP3A4ARNPC1CYP1A2
SCHEMBL20108861 0.77 TOP1 (0.41) CYP2C9CYP3A4TOP1PARP1KDM4E
SCHEMBL20108858 0.76 TOP1 (0.38) CYP2C9CYP1A2CYP2C19TOP1DHODH
SCHEMBL20108848 0.74 CCR1 (0.39) CYP2C9CYP3A4ARCYP2D6TOP1
SCHEMBL17403775 0.73 PARP1 (0.46) NPC1RAB9ATOP1PARP1KDM4E
SCHEMBL20250489 0.73 MAPK13 (0.43) CYP2C9CYP3A4ARNPC1CYP1A2
SCHEMBL20250399 0.73 PARP1 (0.45) RAB9APARP1KDM4EALDH1A1MAPT
SCHEMBL20108901 0.72 CCR1 (0.33) CYP3A4ARCYP2D6KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2021-10-26 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD2, OCIAD1, PPOX CYP2C9 400/4885CYP3A4 529/4885AR 3068/4885
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD2, OCIAD1, PPOX CYP2C9 400/4885CYP3A4 529/4885AR 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.